The Middle East and Africa Advanced Wound care market has been estimated at USD 0.54 billion in 2021 and is projected to reach USD 0.67 billion by 2026, at a CAGR of 4.33% during the forecast period.
Advanced wound care products provide much-needed relief to people suffering from chronic wounds, which take a significant amount of time to heal and are expensive to treat. Technology in this area has grown manifold. Advanced wound care products are gradually replacing traditional care products due to their efficacy and usefulness in managing wounds by enabling faster healing.
This market offers solutions to patients suffering from chronic wounds by providing them readily accessible and reasonably priced products that can be used at one’s own convenience. Treatment in advanced wound care includes interventions therapies and products such as collagen products, foam dressings, hydrocolloids, antimicrobial dressings, film dressings, alginate dressings, gauze composites, and hydrogels. As technology progresses and becomes more viable, the quality of life of patients afflicted with chronic wounds rises.
This market is mainly driven by technological advances, problems associated with ineffective traditional wound healing methods, initiatives taken by the government, and a pressing need for swift and safer treatment of chronic wounds. Attempts to lower the duration of hospital stay to reduce surgical healthcare expenses and the growing inclination towards products that enhance therapeutic outcomes are also driving the demand for the advanced wound care market. However, the High cost associated with the treatment and reimbursement issues for the new technologies serve as factors that hinder the market.
This research report on the MEA Advanced Wound Care Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End-User:
By Country:
The MEA market, which consists of fast-developing economies, has remained largely untapped. However, this market is expanding steadily and has created abundant opportunities for the launch of new products. This region is projected to be the fastest-growing market for Advanced Wound care products for the next decade. In terms of revenue, South Africa leads the market in this region. Rapid urbanization and the rising number of chronic diseases have made this region an area of enormous potential and opportunities.
The market has more significance with trends showing that people desire more efficient solutions for their illnesses. Furthermore, this technology is especially inclined towards the elderly population, for whom accessible healthcare is paramount.
KEY MARKET PLAYERS:
A few of the dominating companies in the MEA advanced wound care market profiled in this report are Acelity L.P., Inc., Smith and Nephew Plc., Mölnlycke Health Care, ConvaTec, Inc., Coloplast Corp., 3M Healthcare, Medtronic, Integra Lifesciences Corporation and Organogenesis Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Type
5.1.1 Dressings
5.1.2 Therapy Devices
5.1.3 Active wound care
5.2 By Application
5.2.1 Skin ulcers
5.2.2 Surgical wounds
5.2.3 Burn wounds
5.3 By End User
5.3.1 In-patient services
5.3.2 Out-patient services
6.1 Middle-East
6.2 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acelity
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Coloplast
8.3 3M Health care
8.4 Medtronic
8.5 Integra Lifesciences
8.6 Derma Sciences
8.7 ConvaTac
8.8 Smith & Nephew
8.9 Molnylcke
8.10 Organogenesis
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
Related Reports
